by International Federation of Psoriasis Associations with support from Lucid
by Sanofi Diabetes
by Astellas Pharma Ltd with support from Wizzard
by Boehringer Ingelheim with support from infill Kommunikation GmbH
by Crohn’s and Colitis UK with support from Healthcare Solutions PR
by GSK with support from emotive
by Janssen with support from Havas Lynx
by Janssen with support from Havas Lynx
Schizophrenia affects one person in every hundred. The condition can be frightening and debilitating with symptoms preventing the patient from acknowledging or understanding their condition. Our challenge was to educate, inform and empower patients across the world to enable them to understand the benefits of continuous medication and communicate their needs to their healthcare team, ultimately resulting in better outcomes for everyone. The campaign has reached almost half a million patients worldwide in 23 languages, with 20 per cent of them meeting a tangible campaign objective.
Janssen are doing excellent work in this area, which is very much underserved. Given that compliance is such a major problem with schizophrenia this is a really big step. The website is very appealing visually and the animations are extremely clever. The global reach was also impressive.
Entry deadline | 26 August 2022 |
Extended entry deadline | 2 September 2022* *additional fee applies |
Judging Day | 6 October 2022 |
Company/Team of the Year Interviews | 21 October 2022 |
PMEA Event | 23 November 2022 |